Press release
Global Point of Care Infectious Disease Market Economic Performance Evaluation By 2026: Key Players are Abbott, Danaher Corporation, Roche, BD, Trinity Biotech, Cardinal Health, Thermo Fisher Scientific, Meridian Bioscience Inc., Sekisui Diagnostics, LLC
Global Point of Care Infectious Disease Market
Global Point of Care Infectious Disease Market of which point of care infectious disease is a part of is expected to grow from its initial estimated value of USD 21.85 billion in 2018 to an estimated value of USD 41.65 billion by 2026.
Download Free | Sample Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-point-of-care-infectious-disease-market
Global point of care infectious disease market is expected to grow with a steady CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018, and the historic year of 2017. This rise in market value can be attributed to rising advancements in the market resulting in innovative product offerings.
Key Players: Global Point of Care Infectious Disease Market
Abbott, Danaher Corporation, Roche, BD, Trinity Biotech, Cardinal Health, Thermo Fisher Scientific, Meridian Bioscience Inc., Sekisui Diagnostics, LLC, OraSure Technologies, Quidel, Siemens Healthineers, Chembio Diagnostic Systems, Inc., MedMira Inc., Calypte Biomedical and others
Segmentation: Global Point of Care Infectious Disease Market
By Technological Offering
Solid Phase
Lateral Flow
Agglutination Assays
Flow-Through
By Clinical Application
Tropical Diseases
Inflammatory Diseases
Liver Disorders
HIV
Respiratory Disorders
Hospital Acquired Infections (HAIs)
Sexually Transmitted Diseases
Others
By End-User
Hospitals
Home-Care
Clinics
Diagnostic & Research Laboratories
Others
By Geography
North America
South America
Europe
Asia-Pacific
Middle East & Africa
Before Buying | Inquire about this Report at https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-point-of-care-infectious-disease-market
Market Drivers: Global Point of Care Infectious Disease Market
Increase in demand from developing economies due to the lack of infrastructure of research and diagnostic laboratories; this factor is expected to act as a driver for the market growth
Increasing prevalence of infectious diseases globally is expected to be one of the major factors driving the market growth
Market Restraint: Global Point of Care Infectious Disease Market
Time consuming and presence of strict regulations associated with the approval and commercialization of point-of-care devices is one of the major factors restraining the market growth
Key Developments in the Market:
In July 2018, Abbott announced the launch of a new point-of-care test in Netherlands for the detection of HIV infection. The test termed as “m-PIMA HIV-1/2 VL”. The test helps in identifying the treatment options for the patients in a single visit as it delivers the results of test within 70 minutes.
In January 2018, Siemens Healthcare GmbH announced that they had completed the acquisition of Fast Track Diagnostics. The acquisition will help in improving the service capabilities of Siemens infectious disease diagnostic solutions and also help in enhancing the product portfolios of the company.
Competitive Analysis: Global Point of Care Infectious Disease Market
Global point of care infectious disease market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of point of care infectious disease market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Reasons to Purchase this Report:
Current and future of global point of care infectious disease market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Read More about This Report at https://databridgemarketresearch.com/reports/global-point-of-care-infectious-disease-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Point of Care Infectious Disease Market Economic Performance Evaluation By 2026: Key Players are Abbott, Danaher Corporation, Roche, BD, Trinity Biotech, Cardinal Health, Thermo Fisher Scientific, Meridian Bioscience Inc., Sekisui Diagnostics, LLC here
News-ID: 1693336 • Views: …
More Releases from Data Bridge Market Research
Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 t …
Precision gearbox market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to reach at an estimated value of USD 5.9 billion by 2029 and grow at a CAGR of 9.1% in the above-mentioned forecast period.
Market Overview
This precision gearbox market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market…
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecas …
Data Bridge Market Research analyses that the global neuropathic pain market, which was USD 5.86 billion in 2023, is expected to reach USD 11.86 billion by 2031, and is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031.
Market Overview
Neuropathic pain is a type of chronic pain caused by damage or dysfunction of the nervous system. It often presents as burning, shooting, or electric shock-kind…
Radiology market registering a CAGR of 6.20% during the forecast period of 2022- …
Radiology market was valued at USD 26.6 billion in 2021 and is expected to reach USD 43.04 billion by 2029, registering a CAGR of 6.20% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Overview
Radiology (also referred as diagnostic imaging) includes multiple tests are included in the process, which…
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportun …
Global Cervical Retractors Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. Cervical Retractors market is supposed to grow during the forecast period due to growing demand…
More Releases for Disease
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,…
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
